Analysis – Page 417 – Goldea Capital

Nexxen Partners with Unity to Deliver In-App Video Scale to Advertisers

Written by Customer Service on May 6, 2026. Posted in Public Companies.

High-attention mobile gaming environments unlock AI-resilient reach beyond the browser NEW YORK, May 06, 2026 (GLOBE NEWSWIRE) — Nexxen, the advertising technology platform powered by unique data and media, today announced a partnership with Unity, the world’s leading game engine, delivering new AI-resilient and non-cookie-dependent video scale to advertisers and agencies. Now integrated into Nexxen’s platform, Unity’s in-app mobile supply expands buyers’ access to premium mobile environments and gaming inventory through its demand-side platform (“DSP”), Nexxen DSP, as well as third-party DSPs. Mobile gaming represents one of the most time-intensive forms of engagement on phones – a 2025 report found that the average mobile gamer spends approximately 8.5 hours per week playing, often while second screening on TV. Unity powers...

BioAdaptives, Inc. Launches MyndRenew™ to Complete the 24-Hour Brain Performance Cycle

Written by Customer Service on May 6, 2026. Posted in Public Companies.

New Nighttime Supplement Targets What Happens — or Fails to Happen — While You Sleep LAS VEGAS, May 06, 2026 (GLOBE NEWSWIRE) — via IBN — More than 1 in 3 American adults report insufficient sleep — a deficit that research increasingly links to measurable declines in next-day cognitive performance. Yet the supplement industry has focused almost exclusively on the waking hours, leaving the brain’s critical overnight recovery window largely unaddressed. BioAdaptives, Inc. (OTC: BDPT) today announced the launch of MyndRenew™, a nighttime dietary supplement formulated to support sleep quality and the brain’s natural overnight recovery processes. MyndRenew™ is the nighttime component of the Company’s MyndSystem™ platform — a first-of-its-kind approach to cognitive support that spans the full 24-hour...

Vermont Renewable Gas Reaches Agreement with State Environmental Regulators, Advancing Lyndon Renewable Energy Project

Written by Customer Service on May 6, 2026. Posted in Public Companies.

IRVINE, CA, May 06, 2026 (GLOBE NEWSWIRE) — Clean Energy Technologies, Inc. (Nasdaq: CETY) (“CETY” or the “Company”), a clean energy technology and solutions provider focused on converting waste and heat into power and fuels, today announced execution by its affiliate, Vermont Renewable Gas (VRG), of a Memorandum of Understanding (MOU) with the Vermont Agency of Natural Resources, marking a significant milestone in the development of VRG’s proposed 2.2 MW renewable energy facility in Lyndon, Vermont. The MOU, filed with the Vermont Public Utility Commission, reflects a comprehensive agreement on environmental and regulatory matters between VRG and Vermont’s primary environmental oversight agency and establishes a clear framework for project approval and ongoing compliance. A Project Aligned with Vermont’s Environmental StandardsVermont...

Actuate Therapeutics Announces Key Appointment of Industry Veteran to Board of Directors

Written by Customer Service on May 6, 2026. Posted in Public Companies.

Martin Huber, MD brings deep expertise in oncology drug development, regulatory strategy, and commercialization of novel therapies CHICAGO and FORT WORTH, Texas, May 06, 2026 (GLOBE NEWSWIRE) — Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers, today announced the appointment of Martin Huber, MD, as an Independent Director, effective immediately. This appointment strengthens Actuate’s leadership team as it advances elraglusib across multiple difficult-to-treat cancer indications toward registration studies and commercialization. “We are pleased to welcome Marty to our Board of Directors. His dedication and expertise are going to prove invaluable to our mission, and we are excited...

Runway Growth Finance Corp. Announces Second Quarter 2026 Dividend of $0.33 per Share

Written by Customer Service on May 6, 2026. Posted in Dividend Reports And Estimates.

MENLO PARK, Calif., May 06, 2026 (GLOBE NEWSWIRE) — Runway Growth Finance Corp. (Nasdaq: RWAY) (“Runway Growth” or the “Company”), a leading provider of flexible capital solutions to late- and growth-stage companies seeking an alternative to raising equity, today announced that its Board of Directors has declared a second quarter 2026 cash distribution of $0.33 per share. The following shows the key dates of the second quarter 2026 dividend: Declaration Date: May 5, 2026Record Date: May 18, 2026Payment Date: June 2, 2026 Runway Growth generally intends to distribute, out of assets legally available for distribution, substantially all of its available earnings, on a quarterly basis, subject to the discretion of the Board of Directors. Any distribution by the Company will depend on the Company’s earnings, financial condition,...

Firm Capital Property Trust Closes $8.5 Million MHC Acquisition, Advances $218 Million Portfolio Transaction

Written by Customer Service on May 6, 2026. Posted in Mergers And Acquisitions.

TORONTO, May 06, 2026 (GLOBE NEWSWIRE) — Firm Capital Property Trust (“FCPT” or the “Trust“) (TSX: FCD.UN) is pleased to announce the closing of the previously announced acquisition of a 50% interest in a 103 site Manufactured Home Community (“MHC”) located in Didsbury, Alberta for $8.5 million (100% ownership) excluding transaction costs. The Trust closed on this acquisition through its existing joint venture arrangement with SunPark Communities, LP (“SunPark”), such that the Trust owns 50% of this MHC and SunPark the remaining 50%. This acquisition strengthens the Trust’s growing MHC platform, a sector characterized by stable occupancies and consistent cash flows. The acquisition aligns with the Trust’s consistent focus on capital preservation and disciplined investing while expanding its presence in Western...

Pathos AI Acquires Majority Stake in DeuterOncology to Advance Next-Generation MET Inhibitor Identified by Pathos Foundry Platform

Written by Customer Service on May 6, 2026. Posted in Mergers And Acquisitions.

Transaction marks one of the first clinical-stage oncology acquisitions sourced, evaluated, and executed through an AI-powered drug development platform NEW YORK, May 06, 2026 (GLOBE NEWSWIRE) — Pathos AI, a clinical-stage AI and technology company advancing its own pipeline of cancer therapies, today announced the acquisition of a majority stake in DeuterOncology, a Belgium-based company developing DO-2, a third-generation MET kinase inhibitor for patients with MET-altered cancers. The asset was systematically identified, evaluated, and advanced to acquisition through the Pathos Foundry platform. Identified by Foundry As part of its core operations, Pathos utilizes Foundry to continuously analyze large-scale clinical and scientific datasets, including conference proceedings, regulatory filings, published trial data, and proprietary...

Cannara Completes Acquisition of Medican Organic Inc.

Written by Customer Service on May 6, 2026. Posted in Mergers And Acquisitions.

MONTREAL, May 06, 2026 (GLOBE NEWSWIRE) — Cannara Biotech Inc. (“Cannara”, the “Company”, “us” or “we”) (TSX: LOVE) (OTCQX: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis products at affordable prices, with two mega facilities based in Québec spanning over 1,600,000 sq. ft., today announced the closing of a transaction to acquire all of the shares of Medican Organic Inc. (“Medican”), a wholly owned subsidiary of BZAM Ltd., for an aggregate purchase price of $2.8 million. This acquisition completes Cannara’s prior acquisition of its Valleyfield cultivation and manufacturing facility, purchased from Medican on June 8, 2021. The acquisition was completed following Medican’s exit from proceedings under the Companies’ Creditors Arrangement Act (“CCAA”) involving Medican’s parent company. Since the initial...

Currenc Group Announces Extension of Exclusivity Period for Proposed Reverse Merger with Animoca Brands Corporation Limited

Written by Customer Service on May 6, 2026. Posted in Mergers And Acquisitions.

Parties Extend Exclusivity Through June 30, 2026, Reaffirming Commitment to Proposed Transaction SINGAPORE, May 06, 2026 (GLOBE NEWSWIRE) — Currenc Group Inc. (Nasdaq: CURR) (“Currenc” or the “Company”), a fintech pioneer empowering financial institutions worldwide with artificial intelligence (“AI”) solutions, today announced that it has entered into an Amendment Deed with Animoca Brands Corporation Limited (ACN: 122 921 813) (“Animoca Brands”) and the Company’s Chairman and Chief Executive Officer, Alexander King Ong Kong, extending the exclusivity period under the previously disclosed term sheet for their proposed reverse merger (the “Proposed Transaction”) from three months from the original execution date to June 30, 2026. Transaction Background On November 2, 2025, Currenc and...

SeaStar Medical to Report First Quarter Financial Results on May 13, 2026

Written by Customer Service on May 6, 2026. Posted in Public Companies.

DENVER, May 06, 2026 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, announced today that it will report its first quarter financial results after market close on Wednesday, May 13, 2026, and host a webcast and conference call to discuss its financial results and business progress.Date/Time: Wednesday, May 13, 2026, at 4:30 p.m. ET / 2:30 p.m. MT Webcast: The live webcast and replay can be found here. Register for the call: Preregistration is required to attend the live call and can be accessed here. A pin code and dial in number will be provided with registration. A replay of the call will be available after 7:30 p.m. ET and can be accessed here. About...

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals